Eisai
4523.T
#2079
Rank
โ‚น890.54 B
Marketcap
โ‚น3,155
Share price
6.09%
Change (1 day)
20.95%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2026 (TTM): โ‚น33.16 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚น5.44 Billion. In 2025 the company made an earning of โ‚น40.34 Billion a decrease over its 2024 earnings that were of โ‚น50.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น33.16 B-17.78%
2025 โ‚น40.34 B-20.48%
2024 โ‚น50.73 B2.42%
2023 โ‚น49.53 B-2404.04%
2022 -โ‚น2.15 Billion-103.6%
2021 โ‚น59.77 B-39.81%
2020 โ‚น99.31 B7.44%
2019 โ‚น92.43 B17.22%
2018 โ‚น78.85 B86.16%
2017 โ‚น42.35 B-23.52%
2016 โ‚น55.38 B26.97%
2015 โ‚น43.62 B22.3%
2014 โ‚น35.66 B-46.07%
2013 โ‚น66.13 B-21.85%
2012 โ‚น84.62 B-20.59%
2011 โ‚น106.57 B-8.91%
2010 โ‚น117.00 B19.21%
2009 โ‚น98.15 B